Shares of Cell Therepautics (CTIC) lose 11.6% in premarket trading after the firm announces that...

|About: CTI BioPharma Corp. (CTIC)|By:, SA News Editor

Shares of Cell Therepautics (CTIC) lose 11.6% in premarket trading after the firm announces that it entered an agreement where it will sell $20M of its Series 14 preferred shares and warrants in order to purchase common stock in a registered offering to 2 institutional investors.